Exploiting metabolic vulnerabilities of Non small cell lung carcinoma
Open Access
- 1 February 2020
- journal article
- review article
- Published by Elsevier in Seminars in Cell & Developmental Biology
- Vol. 98, 54-62
Abstract
No abstract availableKeywords
Funding Information
- Generalitat de Catalunya
- Fundación Científica Asociación Española Contra el Cáncer
- Instituto de Salud Carlos III
- Ministerio de Economía y Competitividad
- Departament de Salut, Generalitat de Catalunya
- H2020 Marie Skłodowska-Curie Actions
This publication has 66 references indexed in Scilit:
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of CancerCancer Cell, 2013
- LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug PhenforminCancer Cell, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Sugar-free approaches to cancer cell killingOncogene, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Survival of Cancer Cells Is Maintained by EGFR Independent of Its Kinase ActivityCancer Cell, 2008
- Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancerOncogene, 2006